Children at risk for multiple sclerosis (MS) might find some protection from the diseaseby spending more time in the sun, a small study suggests.
Although MS is rare in children and young adults, those with relatives who have the condition have increased odds of developing the disease early. Exposure to sunlight may cut their risk in half, researchers say.
Multiple sclerosis (MS) patients undergoing a treatment that depletes a type of immune cell that fuels MS attacks still have a strong response to mRNA COVID-19 vaccines, a new study finds.
"The message from this study is clear — it is worthwhile for patients with MS receiving [anti-CD20] treatment to get a COVID-19 vaccine, which will prevent severe illness," said researcher E. John Whe...
Multiple sclerosis (MS) patients diagnosed with colon cancer may have a greater risk of dying from cancer or other causes in the next six months to year than colon cancer patients without MS, a Canadian study finds.
"These results warrant further investigation to determine what factors may lead to shorter survival times," said study author Dr. Ruth Ann Marrie, a professor of neurology at ...
Depression and multiple sclerosis (MS) tend to travel together, new research finds, and when they do the chances of dying during the next decade can be up to five times greater than it is for those with neither condition.
Exactly why the combination is so lethal is not fully understood, but several factors may be at play, explained study author Dr. Raffaele Palladino, a research associate...
COVID-19 vaccines trigger antibody production in most people who have weakened immune systems, but a new study reveals that their responses are weaker than in healthy people.
"Some of our patients have been hesitant about getting vaccinated, which is unfortunate because they are at increased risk of having more severe cases of COVID-19 if they happen to get infected, compared to those not...
A new study may help explain why people with multiple sclerosis (MS) experience worsening disability while those with two related diseases do not.
MS causes permanent brain and spinal cord scarring, and researchers investigated whether the same damage accompanies two rarer, similar diseases in which the immune system also attacks the central nervous system.
While multiple sclerosis can cause a wide swath of symptoms and challenges for anyone diagnosed with the autoimmune disease, a new study finds that race may play a role in disease severity.
Researchers discovered that Black individuals with MS may be more severely affected by the disease, but also that this added impact persisted even when differences in income were considered. The same w...
A diet designed to boost brain health appears to benefit people with multiple sclerosis (MS), new research suggests.
For the study, a team from Icahn School of Medicine at Mount Sinai in New York City examined 185 people diagnosed with MS within the past five years. Each had MRI brain scans and responded to detailed questionnaires.
The upshot: Those who ate more of the "good" foods ...
There's some reassuring news for women with multiple sclerosis (MS): Having the neurological disease won't affect health outcomes if breast cancer strikes.
"Although multiple sclerosis and its complications remain the most common cause of death in people with MS, cancer is the second or third most common cause of death," noted study lead author Dr. Ruth Ann Marrie, of the University of M...
People with multiple sclerosis (MS) may be wondering if they should get a COVID-19 shot, and the answer is definitely yes, an expert says.
"The big takeaway message is the COVID-19 vaccine is strongly recommended for patients with multiple sclerosis," said Dr. Nancy Sicotte, director of the Multiple Sclerosis and Neuroimmunology Program at Cedars-Sinai in Los Angeles.
Stem cell transplants may have long-lasting benefits for some people with aggressive cases of multiple sclerosis, a new study suggests.
Italian researchers found that among 210 multiple sclerosis (MS) patients who received a stem cell transplant -- with cells from their own blood -- two-thirds saw no worsening in their disability 10 years out.
Researchers say a multiple sclerosis drug meant to slow physical disability also shows promise in improving mental acuity in people who are living with secondary progressive MS, an advanced form of the disease.
The new study found that people taking the drug, called siponimod, for one to two years showed improvements in "cognitive processing speed" compared to those who took a placebo.
How does having multiple sclerosis (MS) affect a person's odds for cancer? The answer may depend on the type of cancer, new research shows.
The study found that MS patients do have much greater odds of developing bladder cancer compared to people without the illness. But there was good news, too: Their risk of breast and colon cancer is no higher than for people who don't have MS, accordi...
A new immunotherapy that has shown success against multiple sclerosis in animals could be promising for humans, a new study suggests.
Researchers at Thomas Jefferson University in Philadelphia are studying a drug that would prevent immune system cells from attacking the myelin sheath, a protective layer that surrounds nerve cells. With MS, the body's immune system attacks the central nerv...
Pregnancy can delay the onset of multiple sclerosis (MS) by more than three years, researchers report.
The international study found those who'd been pregnant had their first MS symptoms an average of 3.3 years later than those who'd never been pregnant. Having carried a baby to term delayed MS onset by an average of 3.4 years, the researchers determined.
More than three-quarters of Americans with multiple sclerosis (MS) experience financial difficulties that often prevent them from getting treatment, new research claims.
"Our study results demonstrate the high prevalence of financial toxicity for MS patients and the resulting decisions patients make that impact their health care and lifestyle," said study author Dr. Gelareh Sadigh, an...
Despite the existence of conventional medications to manage multiple sclerosis (MS) symptoms, a majority of patients also rely on alternative therapies, including vitamins, exercise and marijuana, a new survey suggests.
For the study, researchers at Oregon Health and Science University in Portland asked MS patients if they used "complementary and alternative therapies" -- medicines a...
Air pollution might increase the risk for multiple sclerosis (MS), Italian researchers report.
They found that in places with low levels of tiny particles of air pollution called particulate matter, the risk for MS was lower than in areas where those levels were high. In urban areas, the risk was 29% higher than in rural areas.
A new blood test might help doctors predict whether someone's multiple sclerosis may soon get worse.
The test looks for a substance called neurofilament light chain. It's a nerve protein that can be detected when nerve cells die. People with higher levels of it were more likely to have worsening MS effects within the next year.
Multiple sclerosis can cause weakness, pain, fatigue and vision problems. The disease also appears to increase the odds of heart disease and stroke, new research suggests.
Multiple sclerosis (MS) is a central nervous system disorder that can affect movement. The British study found that people with MS were nearly one-third more likely to have "macrovascular disease." Those are condit...
Brain inflammation may be more of a factor in dementia than previously believed, a new British study suggests.
"We predicted the link between inflammation in the brain and the buildup of damaging proteins, but even we were surprised by how tightly these two problems mapped on to each other," said co-author Thomas Cope of the Department of Clinical Neurosciences at the University of Ca...
The cost of essential medications for multiple sclerosis have nearly tripled this decade, despite the release of the first generic MS drug, a new study shows.
The 2015 release of glatiramer acetate -- the generic version of Copaxone -- did nothing to halt skyrocketing prices for MS medications, said lead researcher Daniel Hartung. He's an associate professor of pharmacy with Oregon St...
If you have a neurological disorder, a video chat with your doctor might be as good as an office visit for checking on your condition.
That's the conclusion of researchers who analyzed 101 studies on telemedicine use for concussion, traumatic brain injury, dementia, epilepsy, headache, multiple sclerosis, movement disorders, neuromuscular conditions and general neurology.
A variant of a common herpes virus may play a role in the development of multiple sclerosis (MS), Swedish researchers say.
They analyzed the blood of about 8,700 MS patients and a control group of more than 7,200 people without MS. They were looking for antibodies against proteins of two variants (A and B) of human herpesvirus 6 (HHV-6), which has been linked with MS.
Medicare patients with multiple sclerosis (MS) saw their medication costs soar by more than sevenfold over a decade, a new study finds.
It's no secret that the costs of MS drugs have skyrocketed in recent years. When the first so-called disease-modifying drugs were approved starting in the 1990s, they cost roughly $8,000 to $11,000 per year, according to the National Multiple Sclerosi...
Surgery is safe for people with multiple sclerosis (MS), a new study finds.
"The idea that patients with MS might be at an increased risk of relapse following surgery isn't necessarily the case, so we need to be careful delaying important surgeries," said study first author Dr. Lindsey De Lott. She is an assistant professor of neurology at the University of Michigan, in Ann Arbor.
Obesity can worsen multiple sclerosis symptoms, researchers say.
Their study involved 140 patients with the relapsing-remitting form of MS, which means patients have periods of attacks (relapses), followed by periods of remission with no or few symptoms. The researchers found that obesity at the time of diagnosis was associated with more severe disability.
Multiple sclerosis, epilepsy and Parkinson's can be physically taxing conditions, but new research shows they exact a huge financial toll as well.
Over a 12-year period, out-of-pocket costs for Americans with these illnesses jumped, with the biggest increase seen among people with multiple sclerosis (MS). Those patients paid 20 times more for their drugs in 2016 than they did in 2004...